Blog Archives

Blockchain and Pharmaceutical Data Management

Blockchain, originally devised for the digital currency Bitcoin, is now being widely adopted by other industries including pharmaceuticals where it has the potential to benefit every stage of the development lifecycle. Blockchain could be particularly useful where data is being

Posted in Apple, Apps, Patient Safety, Software Development, Technology

Apple Heart Study enrolls more than 400,000

Mobile technologies such as the iWatch are now fitted with high-quality sensors that can measure and detect clinical changes in our bodies in entirely new and insightful ways. For example, Stanford Medicine and Apple have enrolled more than 400,000 participants

Posted in Apple, Apps, Patient Safety, Validation

Medication reminder apps improved heart patients’ adherence

A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not. The investigation involved 163 adult participants with an average age of 58 years

Posted in Apps, Patient Safety, Regulation

Personalised care for Gestational Diabetes

GDm-Health is a prescribed digital therapeutic for the management of gestational diabetes at home and has been clinically evaluated in over 1,000 patients at the Royal Berkshire NHS Foundation Trust with transformative results, including: 25% reduction in clinical visits 1

Posted in Apple, Apps, Patient Safety, Regulation, Software Development, Technology, Validation

Apps Improve Medication Adherence

A recent survey shows that in the US at least half of the nation’s medication users aren’t taking their drugs as prescribed – costing some $300 billion a year in avoidable healthcare expenses, or $1,000 per person – medication adherence

Posted in Apps, Patient Safety, Technology

mHealth Apps Numbers Double

Mobile health app numbers almost double in the two years from 2015 to exceed 318,500, with more than 200 new apps launched every day, according to a new report. The work, by the IQVIA Institute for Human Data Science, also

Posted in Apps, Patient Safety, Technology

Apps as medical devices – UK regulator updates its guidance

The MHRA has updated its guidance on whether a health app should be subject to medical device oversight. A number of apps and pieces of stand-alone software that are already on the market have so far been classified as medical

Posted in Apps, Patient Safety, Regulation, Software Development, Technology, Validation

Better pharmacovigilance through social media

Monitoring conversations on Facebook, Twitter, and patient forums to identify and assess adverse drug reactions (ADRs) is becoming very popular with pharma companies and healthcare organisations providing useful data for strategy development, competitive research and patient segmentation. But what remains

Posted in Patient Safety, Regulation, Technology

AZ and NCI to develop a mobile app to manage side effects

It has been reported that AstraZeneca and the NCI will test whether a mobile app can improve treatment for women who are taking AstraZeneca’s Lynparza and cediranib cancer drug combo. The smartphone app links to a web portal that allows doctors and

Posted in Apps, Patient Safety, Software Development, Technology, Validation

It’s now official – using a mobile app can improve pharmacovigilance

A recent study has shown that by using a mobile app the time taken to prepare and submit a voluntary adverse event (AE) report can be reduced significantly. The study also showed that reports received via the mobile app were

Posted in Apps, Patient Safety, Regulation, Software Development, Technology, Validation